Adult Vaccines Market Scope And Analysis

  • Report Code : TIPRE00007244
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi del mercato dei vaccini per adulti e concorrenti entro il 2025-2031

Buy Now

Adult Vaccines Market Report Adult Vaccines Market Size and Share Adult Vaccines Market Scope and Analysis

Adult Vaccines Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Tipo
  • vaccino preventivo
  • vaccino terapeutico
By Malattia [influenza, meningococco, herpes zoster, pneumococco, difterite, tetano, pertosse
  • DTP
  • epatite
  • morbillo
  • parotite
  • rosolia e varicella
By Tecnologia
  • vaccini non vivi attenuati
  • vaccini virali/batterici inattivati
  • vaccini tossoidi
  • vaccini ricombinanti
  • vaccini coniugati
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • AstraZeneca
  • Bharat Biotech
  • Dynavax Technologies Corporation
  • GlaxoSmithKline
  • Johnson and Johnson
  • Merck and Co
  • Novartis
  • Pfizer
  • Sanofi Pasteur